JXJie Xie

Jie Xie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jie Xie has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Heng Li

    Department of Laboratory Medicine, Chongqing Center for Clinical Laboratory, Chongqing Academy of Medical Sciences, Chongqing General Hospital, School of Medicine, Chongqing University, Chongqing, China

    1 shared publication
  • Hong Zhang

    Department of Laboratory Medicine, Chongqing Center for Clinical Laboratory Chongqing Academy of Medical Sciences Chongqing General Hospital School of Medicine Chongqing University Chongqing P. R. China

    1 shared publication
  • Liangting Wang

    Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038, China

    1 shared publication
  • Sergio Bernardini

    Department of Experimental Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy

    1 shared publication
  • Wei Gu

    Center of Smart Laboratory and Molecular Medicine, School of Medicine, Chongqing University, Chongqing 400030, China

    1 shared publication
  • Xiaolin Hu

    Department of Laboratory Medicine, Chongqing Center for Clinical Laboratory, Chongqing Academy of Medical Sciences, Chongqing General Hospital, School of Medicine, Chongqing University, Chongqing 401147, China

    1 shared publication

Latest Publications

  • Open Access

    High-fidelity molecular decoding through tile-guided in situ self-assembly

    by Xiaolin Hu, Xinlin Guo, Jie Xie, Liangting Wang, Zhengheng Yu, Heng Li, Xiaopei Qiu, Sergio Bernardini, Wei Gu, Yang Luo, et al.

    High-fidelity profiling of intracellular biomarkers is crucial for deciphering tumorigenesis and progression, as well as classifying cell types. Conventional techniques suffer from high background interference and poor stability due to the scattered, point-like signals. Herein, we present a DNA tile–driven in vivo logical encoding self-assembly (TILES) strategy for robust and signal-amplified imaging of multiple biomarkers in cancer cells and tumor-bearing mice. Capitalizing on AND-gated logic operations, the TILES assay enables confined recognition of dual biomarkers to initiate the intracellular self-assembly of DNA scaffolds, yielding nanotube-like signals. Owing to the compact nucleic acid framework, DNA scaffolds exhibit an over sevenfold nuclease resistance enhancement than double-stranded DNA probes. Moreover, the structural output, characterized by high-density fluorophore architecture and defined morphology, substantially boosts the visualization and precise classification of diverse cancer types. The proposed strategy provides a robust platform to enable the high-fidelity, multiplexed profiling of intracellular biomarkers and dynamic gene regulatory networks analysis in living organisms.